Home
Home
/
Products
Products
/
Bioactive Compounds
Bioactive Compounds
/
Cell Cycle
Cell Cycle
/
Aurora Kinase
Aurora Kinase
Aurora Kinase
Products (19)
Maleic Acid
CAS No.:
110-16-7
3-(4-(4-(2-(3-((dimethylamino)methyl)phenyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-ethyl-1H-pyrazol-3-yl)phenyl)-1,1-dimethylurea
CAS No.:
942918-07-2
SCH-1473759 hydrochloride
CAS No.:
1094067-13-6
N-(4-((3-(2-Amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine
CAS No.:
945595-80-2
Tak-901
CAS No.:
934541-31-8
At-9283
CAS No.:
896466-04-9
Tak-285
CAS No.:
871026-44-7
Barasertib
CAS No.:
722543-31-9
Cyc-116
CAS No.:
693228-63-6
Sns-314
CAS No.:
1057249-41-8
Xl-228
CAS No.:
898280-07-4
(2R,4R)-1-((3-chloro-2-fluorophenyl)methyl)-4-((3-fluoro-6-((5-methyl-1H-pyrazol-3-yl)amino)pyridin-2-yl)methyl)-2-methylpiperidine-4-carboxylic acid
CAS No.:
1919888-06-4
Pf-03814735
CAS No.:
942487-16-3
Mln8054
CAS No.:
869363-13-3
6-chloro-7-(4-(4-chlorobenzyl)piperazin-1-yl)-2-(1,3-dimethyl-1H-pyrazol-4-yl)-3H-imidazo(4,5-b)pyridine
CAS No.:
1402709-93-6
Tinengotinib
CAS No.:
2230490-29-4
Tas-119
CAS No.:
1453099-83-6
Kw-2449
CAS No.:
1000669-72-6
alisertib sodium anhydrous
CAS No.:
1028486-06-7
Products
CDMO Compounds
API & Candidates
Services
CDMO & Manufacturing
Custom Synthesis
Process Development
Lab To Pilot
Commercialization
Generic APIs
CRO
Preclinical
Pharmacology & Efficacy
DMPK & Bioanalysis
Toxicology & Safety
Disease Models
Technologies
High-Potent
Chiral Synthesis
Cloud Synthesis
Fermentation
Flow Chemistry
Biocatalysis
Support
Regulatory Support
Supply Chain Solutions
About
Perspectives
Contact